Product Images Dopamine Hydrochloride

This text provides important information on how to prevent sloughing and necrosis in ischemic areas. It suggests the use of phentolamine mesylate, an adrenergic blocking agent, which can be administered by infiltrating a saline solution containing 5 to 10 mg of phentolamine mesylate using a syringe with a fine hypodermic needle. Phentolamine should be given as soon as possible within 12 hours after noting the extravasation to cause immediate and conspicuous local hyperemic changes. This can be used as an antidote for peripheral ischemia.*

This is a description of different volumes and concentrations of Hydrochloride Injection, USP containing Dopamine in varying amounts. The injection comes in a 250 mL bottle with either 800 mcg/mL or 1600 mcg/mL, a 500 mL bottle with 400 mcg/mL or 800 mcg/mL, and a 1000 mL bottle with either 200 mcg/mL or 400 mcg/mL.*

This is a product description for two different units of sale of a medication. The first one has an NDC code of 0409-5820-01, a total strength of 200 mg/5mL, and comes in a 25-pack of flip-top vials that contain 40mg/mL of the medication. The second unit has an NDC code of 0409-9104-20, a total strength of 400 mg/10 mL, also comes in a 25-pack of flip-top vials, and also contains 40mg/mL of the medication.*

This text describes the details of Dopamine Hydrochloride injection, 200mg/SmL. It is a sterile, nonpyiogenic, intravenous drug, packaged in a single-dose flip-top vial. It is emphasized to handle it with aseptic technique and dilute it before use. The drug must be checked thoroughly before use, including the clarity and intactness of the vial, and should be discarded if found discolored or has contamination. The drug contains no bacteriostat, and once ejected from the vial, the unused portion must be discarded. The drug has storage temperature restrictions and does not have any dosage instructions available. The text also mentions the manufacturing details and contains some barcode serial numbers.*